A New Era of Proactive Health Intelligence.
Canada's AI-native diagnostic infrastructure. Transitioning from reactive crisis management to anticipatory precision care for all Canadians.
The $700B Macroeconomic Ticking Clock.
Canada's healthcare spend is projected to balloon from $400B today to $700B by 2036. The current trajectory is unsustainable.
The $200B Chronic & Critical Concentration.
The majority of national spend is concentrated in late-stage management of preventable conditions. Clinical intervention at the sub-clinical stage represents the single largest fiscal lever in the Canadian economy.
Late-stage therapeutic interventions vs early detection protocols.
Reactive event management vs proactive plaque visualization.
Complication treatment vs precision glycemic optimization.
Chronic symptom management vs early functional auditing.
A Concentration Crisis.
50% of the $200B aggregate spend is avoidable through high-fidelity diagnostic screening in the initial sub-clinical window.
The 3.1x Acuity Penalty.
Clinical Delta: Detection vs Response Efficiency
Oncology
Cardiovascular
Metabolic
Shifting 10% high-risk saves $20-30B yearly.
Stage 1 survival rate across primary oncological indicators.
Survival rate when detected at Stage 4 reactive diagnosis.
A 15% acute demand reduction eliminates the national backlog in 3-5 years.
PIPEDA Compliant
Sovereign Data Sovereignty
Architected around AI as the operating system of care.
Continuous pattern recognition for early detection. We create a clinical data flywheel that informs population health decisions in real-time.
The Predictive Flywheel
Each diagnostic cycle improves the predictive accuracy for the entire Canadian cohort.
Sub-Clinical Pattern Logic
Detection of sub-clinical anomalies before symptoms manifest in the clinical patient profile.
Canada as a Global Research Premium.
200+ Ethnicities. One Sovereign Dataset.
Indigenous Population
Elevated metabolic and diabetes risk profiling benchmarks.
South Asian
Cardiovascular risk variance and intervention benchmarks.
East Asian
Risk escalation after one decade in North American climates.
Black Canadian
Hypertension prevalence and management gap analysis.
The 10 Baselines.
2-4 hour walk-in. Same-day results. Packages starting <$150.
Capital Moat.
Growing at 23% CAGR. Canada represents the ideal testing ground for sovereign AI health infrastructure.
Regulatory Moat.
Operating within the Canada Health Act framework through voluntary supplemental preventive services.
Voluntary charges for non-public services ensuring broad accessibility without compromising public funding streams.
$500M Public Savings Potential by diverting acute cases to primary prevention and early-stage management.
Path to National Impact.
BENEFIT CORPORATION FRAMEWORK
Foundation
Architecture finalization and sovereign AI model training on core diagnostic benchmarks.
Pilot Launch
Flagship centres opening in Toronto and Vancouver to establish urban data clusters.
Regional Scale
Expansion to 3-5 secondary cities. Integration of corporate health partnerships.
National Reach
Unified coast-to-coast proactive network. Primary provider of preventive health data.
Join the Capital & Strategic Round.
We are seeking partners across Clinical, Technical, Capital, and Strategic domains to redefine the Canadian healthcare sanctuary.